inflammatory inhibitor
81Monoclonal antibodies — A general representation of the methods used to produce monoclonal antibodies. Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are the same because they are made by identical immune cells that are all clones of a unique… …
82Complement system — This article is about an aspect of the immune system. For other uses, see complement (disambiguation). The complement system helps or “complements” the ability of antibodies and phagocytic cells to clear pathogens from an organism. It is part of… …
834-Aminosalicylic acid — Systematic (IUPAC) name …
84Complement component 5 — PDB rendering based on 3cu7. Available st …
85Alzheimer's disease — Alzheimer redirects here. For other uses, see Alzheimer (disambiguation). Alzheimer s disease Classification and external resources …
86Histamine antagonist — A histamine antagonist, commonly referred to as antihistamine, is a pharmaceutical drug that inhibits action of histamine by blocking it from attaching to histamine receptors. Contents 1 Clinical effects 2 Clinical: H1 and H2 receptor antagonists …
87Cannabinoid receptor antagonist — The discovery of the endogenous cannabinoid system led to the development of CB1 receptor antagonists. The first cannabinoid receptor antagonist, rimonabant, was described in 1994. Rimonabant blocks the CB1 receptor selectively and it has been… …
88Theophylline — Systematic (IUPAC) name 1 …
89Catechin — IUPAC name (2R,3S) 2 (3,4 dihydroxyphenyl) 3,4 dihydro 2H chromene 3,5,7 …
90Quercetin — IUPAC name 2 (3,4 dihydroxyphenyl) 3,5,7 trihydroxy 4H chromen 4 one …
